Aegirbio’s Eurostar application concerning “COVID-19 detection” ranked 27th among 550 applicants
Aegirbio's application for financial aid from Eurostar concerning the project “A cost-effective and broadly applicable mimetope based diagnostic platform for high-impact pandemics” was ranked 27th among 550 applications. Aegirbio has, together with its German partner, submitted an application for part-financing of its precise COVID-19 antibody test to Eurostar. The decision whether to grant financing will be taken later.The project aims to develop a new platform for point-of-care (POC) serology tests, with COVID-19 as the first application. Aegirbio’s veritope molecules can be used to react